| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ocugen Inc (NASDAQ: OCGN)
OCGN Technical Analysis
5
| As on 9th Jun 2023 OCGN SHARE Price closed @ 0.46 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.70 & Strong Sell for SHORT-TERM with Stoploss of 3.83 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OCGNSHARE Price
| Open | 0.46 | Change | Price | % |
| High | 0.47 | 1 Day | 0.00 | 0.00 |
| Low | 0.45 | 1 Week | 0.00 | 0.00 |
| Close | 0.46 | 1 Month | -0.25 | -35.21 |
| Volume | 7045000 | 1 Year | -5.00 | -91.58 |
| 52 Week High 5.46 | 52 Week Low 0.45 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| OCGN Daily Charts |
OCGN Intraday Charts |
Whats New @ Bazaartrend |
OCGN Free Analysis |
|
|
OCGN Important Levels Intraday
| RESISTANCE | 0.50 |
| RESISTANCE | 0.49 |
| RESISTANCE | 0.48 |
| RESISTANCE | 0.47 |
| SUPPORT | 0.45 |
| SUPPORT | 0.44 |
| SUPPORT | 0.43 |
| SUPPORT | 0.42 |
OCGN Forecast April 2024
| 4th UP Forecast | 3.87 |
| 3rd UP Forecast | 2.78 |
| 2nd UP Forecast | 2.1 |
| 1st UP Forecast | 1.42 |
| 1st DOWN Forecast | -0.5 |
| 2nd DOWN Forecast | -1.18 |
| 3rd DOWN Forecast | -1.86 |
| 4th DOWN Forecast | -2.95 |
OCGN Weekly Forecast
| 4th UP Forecast | 2.68 |
| 3rd UP Forecast | 1.97 |
| 2nd UP Forecast | 1.53 |
| 1st UP Forecast | 1.09 |
| 1st DOWN Forecast | -0.17 |
| 2nd DOWN Forecast | -0.61 |
| 3rd DOWN Forecast | -1.05 |
| 4th DOWN Forecast | -1.76 |
OCGN Forecast2024
| 4th UP Forecast | 10.04 |
| 3rd UP Forecast | 6.97 |
| 2nd UP Forecast | 5.07 |
| 1st UP Forecast | 3.17 |
| 1st DOWN Forecast | -2.25 |
| 2nd DOWN Forecast | -4.15 |
| 3rd DOWN Forecast | -6.05 |
| 4th DOWN Forecast | -9.12 |
Ocugen Inc ( NASDAQ USA Symbol : OCGN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OCGN Business Profile
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania. Address: 263 Great Valley Parkway, Malvern, PA, United States, 19355
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service